Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
المؤلفون الرئيسيون:	Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2022-06-01
الموضوعات:	angiotensin receptor blockers angiotensin‐converting enzyme inhibitors calcium channel blockers COVID‐19 renin‐aldosterone angiotensin system inhibitors thiazide diuretics
الوصول للمادة أونلاين:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025289